Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

FDA approves new Allegra formulations

March 1, 2000

Zambon presents new PDE4 inhibitors useful for respiratory diseases

Feb. 29, 2000

Discovery to develop aerosolized formulations of Surfaxin

Feb. 28, 2000

New respiratory therapeutics from Zambon act as phosphodiesterase inhibitors

Feb. 28, 2000

PathoGenesis announces approval, distribution agreement for TOBI

Feb. 25, 2000

New treatment for COPD from Ono to enter clinical trials soon

Feb. 24, 2000

Life-saving treatment for pulmonary hypertension in newborn babies featured in NEJM

Feb. 23, 2000

Development of cystic fibrosis therapy advances at SciClone

Feb. 17, 2000

Antiallergic agents from SB act as CCR3 receptor antagonists

Feb. 16, 2000

Neurokinin antagonists in early development at AstraZeneca

Feb. 15, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...